Back to search

Article

Hydroxychloroquine as Adjuvant Therapy with Immunotherapy for Prevention of Activation of Latent Tuberculosis: Restoring Interferon-Gamma Competence in Patients Receiving TNF-Alpha Inhibitors

2026-03-17

Abstract excerpt

<h4>Background: </h4> Tumor necrosis factor-alpha (TNF-α) inhibitors have transformed the management of chronic inflammatory diseases, yet they impose a substantially elevated risk of tuberculosis (TB) reactivation—up to 25-fold depending on the agent used. This risk is principally driven by disruption of granuloma architecture and suppression of interferon-gamma (IFN-γ)–dependent macrophage bactericidal activity....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ffe8af7e-ba14-59e7-b150-7a2cdc3d0c7f
DOI
10.20944/preprints202603.1220.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hydroxychloroquine as Adjuvant Therapy with Immunotherapy for Prevention of Activation of Latent Tuberculosis: Restoring Interferon-Gamma Competence in Patients Receiving TNF-Alpha InhibitorsDOI 10.20944/preprints202603.1220.v1
Select a neighboring publication to make it the new centre.